MARKET

NSPR

NSPR

INSPIREMD
AMEX

Real-time Quotes | Nasdaq Last Sale

4.590
0.000
0.00%
After Hours: 4.600 +0.01 +0.22% 19:16 05/17 EDT
OPEN
4.460
PREV CLOSE
4.590
HIGH
4.740
LOW
4.460
VOLUME
170.54K
TURNOVER
--
52 WEEK HIGH
22.20
52 WEEK LOW
4.230
MARKET CAP
36.29M
P/E (TTM)
-0.3884
1D
5D
1M
3M
1Y
5Y
PreMarket Prep Stock Of The Day: InspireMD
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upco...
Benzinga · 2h ago
InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021
InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), announced today that management will participate at the Investor Summit ...
GlobeNewswire · 3d ago
InspireMD Files For U.S. Patent Titled 'Stent assembly and methods for treatment via body lumens'
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210137712%22.PGNR.&OS=DN/20210137712&RS=DN/202
Benzinga · 4d ago
Schedule For Benzinga's Global Small Cap Conference Thursday, May 13, 2021
Check out the full agenda via Benzinga's Events page: https://www.benzinga.com/events/small-cap/global/#agenda * the list below is limited to some of the publicly-traded companies that will be presenting
Check out the full agenda via Benzinga's Events page:  * the list below is limited to some of the publicly-traded companies that will be presenting · 4d ago
8-K: InspireMD, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 5d ago
BRIEF-InspireMD Announces Appointment Of Katie Arnold To Board
reuters.com · 5d ago
InspireMD Announces Appointment of Katie Arnold to Board of Directors
InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced it has appointed seasoned marketing executive Kathryn (...
GlobeNewswire · 5d ago
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)
Benzinga · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NSPR. Analyze the recent business situations of INSPIREMD through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NSPR stock price target is 16.50 with a high estimate of 16.50 and a low estimate of 16.50.
EPS
Institutional Holdings
Institutions: 6
Institutional Holdings: 43.69K
% Owned: 0.55%
Shares Outstanding: 7.91M
TypeInstitutionsShares
Increased
0
0
New
3
38.75K
Decreased
2
245.19K
Sold Out
5
256.10K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.54%
Healthcare Equipment & Supplies
-0.70%
Key Executives
Chairman/Director
Paul Stuka
Chief Executive Officer/Director
Marvin Slosman
Vice Chairman/Director
Isaac Blech
Chief Financial Officer/Chief Administrative Officer/Treasurer/Secretary/IR Contact Officer
Craig Shore
Executive Vice President
Agustin Gago
Director
Kathryn Arnold
Director
Thomas Kester
Director
Gary Roubin
Independent Director
Michael Berman
Independent Director
Campbell Rogers
No Data
  • All
  • Financials
  • Insiders
More
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Webull offers kinds of InspireMD Inc stock information, including AMEX:NSPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSPR stock methods without spending real money on the virtual paper trading platform.